Inventor · disambiguated record
Andrew J. Mcriner
Also filed as: MCRINER ANDREW · MCRINER ANDREW J
19 granted patents·2 pending applications·40 citations·filing 2003–2017
91Inventor score
Files withFORUM PHARMACEUTICALS INC3KAPLAN ALAN P3DART NEUROSCIENCE CAYMAN LTD2DENALI THERAPEUTICS INC2IRONWOOD PHARMACEUTICALS INC2
Top patents by PatentIndex Score
21 records- 0191US9725453B2Imidazotriazinone compoundsIRONWOOD PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·7 cites·2 claims
- 0291US8222243B2Therapeutic isoxazole compoundsKAPLAN ALAN P·Filed 2008·Granted Jul 17, 2012·8 cites·27 claims
- 0387US9650349B2Therapeutic isoxazole compoundsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted May 16, 2017·3 cites·18 claims
- 0483US8921399B2Therapeutic isoxazole compoundsKAPLAN ALAN P·Filed 2012·Granted Dec 30, 2014·2 cites·21 claims
- 0580US7919626B2Pyrazole compounds and uses thereofHELICON THERAPEUTICS INC·Filed 2007·Granted Apr 5, 2011·4 cites·1 claims
- 0676US9029397B2Therapeutic isoxazole compoundsKAPLAN ALAN P·Filed 2012·Granted May 12, 2015·1 cites·44 claims
- 0775US8591943B2Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitorsDENG YONGQI·Filed 2010·Granted Nov 26, 2013·6 cites·2 claims
- 0872US7417156B2Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimersUNIV JOHNS HOPKINS·Filed 2003·Granted Aug 26, 2008·7 cites·85 claims
- 0967US8791137B2Therapeutic compoundsZHOU XIANBO·Filed 2010·Granted Jul 29, 2014·1 cites·4 claims
- 1067US8399487B2Pyrazole compounds and uses thereofZHOU XIANBO·Filed 2010·Granted Mar 19, 2013·1 cites·27 claims
- 1164US10053467B2Therapeutic isoxazole compoundsDART NEUROSCIENCE CAYMAN LTD·Filed 2017·Granted Aug 21, 2018·0 cites·20 claims
- 1253US9969742B2Imidazotriazinone compoundsIRONWOOD PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·0 cites·3 claims
- 1351US2012157458A1Imidazotriazinone compoundsRIPKA AMY·Filed 2011·Application pending·0 cites
- 1444US9802927B2Oxadiazine compounds and methods of use thereofDENALI THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·0 cites·19 claims
- 1543US9771378B2Fused morpholinopyrimidines and methods of use thereofDENALI THERAPEUTICS INC·Filed 2016·Granted Sep 26, 2017·0 cites·20 claims
- 1639US10370370B2Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsFORUM PHARMACEUTICALS INC·Filed 2016·Granted Aug 6, 2019·0 cites·13 claims
- 1738US10428062B2Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsFORUM PHARMACEUTICALS INC·Filed 2016·Granted Oct 1, 2019·0 cites·13 claims
- 1837US2017247393A1Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine ReceptorsFORUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1936US8703784B2Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycinMENG ZHAOYANG·Filed 2011·Granted Apr 22, 2014·0 cites·10 claims
- 2035US10183938B2Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptorsAXOVANT SCIENCES GMBH·Filed 2015·Granted Jan 22, 2019·0 cites·15 claims
- 2131US9227971B2Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsSIDDIQUI M ARSHAD·Filed 2011·Granted Jan 5, 2016·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Andrew J. Mcriner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →